Guanze Medical Information Industry (Holding) Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
28.00
42.00
34.00
39.00
43.00
33.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-11.00
-26.00
-21.00
-26.00
-6.00
-24.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
23.00
9.00
10.00
3.00
31.00
6.00
Cash Flow from Investing Activities
-31.00
-8.00
-10.00
-9.00
-16.00
-11.00
Cash Flow from Financing Activities
-35.00
41.00
10.00
23.00
-16.00
-4.00
Net Cash Inflow / Outflow
-43.00
43.00
10.00
17.00
-1.00
-9.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Guanze Medical Information Industry (Holding) Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
28.524845072448
1007.94110561731
-979.00
-97.17%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-11.5502365941993
-75.0857537649566
64.00
84.62%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
23.2815385700967
-1.6621151505593
24.00
1500.72%
Cash Flow from Investing Activities
-31.5498295930353
385.22906813718
-416.00
-108.19%
Cash Flow from Financing Activities
-35.2351064337077
-502.243926339466
467.00
92.98%
Net Cash Inflow / Outflow
-43.5033974566462
-118.53602425332
75.00
63.30%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0.140949099525571
0.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 138.13% vs -9.74% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
23.28
9.78
138.13%






